Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Graff

Showing results (111-120 of 117) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 117 results.
European Urology Open Science|December 22, 2021
Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical ProstatectomyKaren A Autio, Emmanuel S Antonarakis, Tina M Mayer, et al.
Prostate Cancer and Prostatic Diseases|February 27, 2019
MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancerNicholas G Nickols, Ramin Nazarian, Shuang G Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 2025
National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design ConsiderationsDavid J Einstein, Melissa L Abel, Jeanny B Aragon-Ching, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 9, 2020
Active lifestyles moderate clinical outcomes in autosomal dominant frontotemporal degenerationK B Casaletto, A M Staffaroni, A Wolf, et al.
Cancer Discovery|December 9, 2024
Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate CancerLisa N Chesner, Fanny Polesso, Julie N Graff, et al.
Medrxiv : the Preprint Server for Health Sciences|April 5, 2023
Axonal damage and astrocytosis are biological correlates of grey matter network integrity loss: a cohort study in autosomal dominant Alzheimer diseaseL Vermunt, C Sutphen, E Dicks, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 9, 2020
Comparison of sporadic and familial behavioral variant frontotemporal dementia (FTD) in a North American cohortHilary W Heuer, P Wang, K Rascovsky, et al.
Pageof 12

Showing results (111-120 of 117) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 117 results.
European Urology Open Science|December 22, 2021
Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical ProstatectomyKaren A Autio, Emmanuel S Antonarakis, Tina M Mayer, et al.
Prostate Cancer and Prostatic Diseases|February 27, 2019
MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancerNicholas G Nickols, Ramin Nazarian, Shuang G Zhao, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 23, 2025
National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design ConsiderationsDavid J Einstein, Melissa L Abel, Jeanny B Aragon-Ching, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 9, 2020
Active lifestyles moderate clinical outcomes in autosomal dominant frontotemporal degenerationK B Casaletto, A M Staffaroni, A Wolf, et al.
Cancer Discovery|December 9, 2024
Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate CancerLisa N Chesner, Fanny Polesso, Julie N Graff, et al.
Medrxiv : the Preprint Server for Health Sciences|April 5, 2023
Axonal damage and astrocytosis are biological correlates of grey matter network integrity loss: a cohort study in autosomal dominant Alzheimer diseaseL Vermunt, C Sutphen, E Dicks, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 9, 2020
Comparison of sporadic and familial behavioral variant frontotemporal dementia (FTD) in a North American cohortHilary W Heuer, P Wang, K Rascovsky, et al.
Pageof 12